Condensed Consolidated Statement of Stockholders Deficit (Unaudited) - USD ($)	Total	Series E, Preferred Stocks [Member]	Common Stock	Additional Paid-In Capital	Retained Earnings (Accumulated Deficit)	Series B Preferred Stock [Member]
Balance, shares at Dec. 31, 2021		35,400	276,383,093			14,462
Balance, amount at Dec. 31, 2021	$ (11,444,945)	$ 3,540,000	$ 276,383	$ 39,412,236	$ (51,133,564)	$ 1,446,200
Issuance of common stock for conversion of Series B preferred stock, shares	221		14,733,333			(221)
Issuance of common stock for conversion of Series B preferred stock, amount	$ 22,100	0	$ 14,734	7,366	0	$ (22,100)
Issuance of common stock for conversion of notes payable and accrued interest payable, shares			32,941,380
Issuance of common stock for conversion of notes payable and accrued interest payable, amount	92,750	0	$ 32,941	59,809	0	0
Issuance of common stock for services, shares			4,000,000
Issuance of common stock for services, amount	20,000	$ 0	$ 4,000	16,000	0	0
Issuance of Series E preferred stock for cash, shares		1,200
Issuance of Series E preferred stock for cash, amount	0	$ 120,000	0	0	0	0
Issuance of consultant stock options	(545,462)	0	0	(545,462)	0	0
Vesting of consultant stock options	736,915	0	0	736,915	0	0
Settlement of derivative liabilities	66,341	0	0	66,341	0	0
Net income	372,002	$ 0	$ 0	0	372,002	$ 0
Balance, shares at Mar. 31, 2022		36,600	328,057,806			14,241
Balance, amount at Mar. 31, 2022	(10,680,299)	$ 3,660,000	$ 328,058	39,753,205	(50,761,562)	$ 1,424,100
Balance, shares at Dec. 31, 2022		40,600	604,150,321			14,421
Balance, amount at Dec. 31, 2022	$ (7,363,543)	$ 4,060,000	$ 604,150	42,196,857	(50,164,550)	$ 1,424,100
Issuance of common stock for conversion of Series B preferred stock, shares	0
Issuance of common stock for conversion of notes payable and accrued interest payable, shares			129,616,384
Issuance of common stock for conversion of notes payable and accrued interest payable, amount	$ 40,971	$ 0	$ 129,617	(88,646)	0	0
Issuance of Series E preferred stock for cash, shares		1,720
Issuance of Series E preferred stock for cash, amount	0	$ 172,000	0	0	0	0
Vesting of consultant stock options	745,448	0	0	745,448	0	0
Settlement of derivative liabilities	30,758	0	0	30,758	0	0
Net income	193,652	$ 0	$ 0	0	193,652	$ 0
Balance, shares at Mar. 31, 2023		42,320	733,766,705			14,241
Balance, amount at Mar. 31, 2023	$ (6,352,714)	$ 4,232,000	$ 733,767	$ 42,884,417	$ (49,970,898)	$ 1,424,100